Antje Arnold

646 total citations
24 papers, 482 citations indexed

About

Antje Arnold is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Antje Arnold has authored 24 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Antje Arnold's work include Glioma Diagnosis and Treatment (8 papers), Neurogenesis and neuroplasticity mechanisms (4 papers) and Pluripotent Stem Cells Research (3 papers). Antje Arnold is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Neurogenesis and neuroplasticity mechanisms (4 papers) and Pluripotent Stem Cells Research (3 papers). Antje Arnold collaborates with scholars based in United States, Germany and United Kingdom. Antje Arnold's co-authors include Alexandra Stolzing, Leili Rohani, Paul Bailey, Adiv A. Johnson, Charles G. Eberhart, Ming Yuan, Eric H. Raabe, Piotr Walczak, Mirosław Janowski and Herbert Zimmermann and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Cancer Research.

In The Last Decade

Antje Arnold

22 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antje Arnold United States 14 251 108 76 66 65 24 482
Julia Pöschl Germany 10 263 1.0× 143 1.3× 68 0.9× 55 0.8× 39 0.6× 11 499
Anke Leinhaas Germany 7 278 1.1× 103 1.0× 90 1.2× 50 0.8× 101 1.6× 8 428
Dao Ly Canada 7 396 1.6× 61 0.6× 53 0.7× 74 1.1× 49 0.8× 11 649
Israel Ben‐Dor Israel 8 304 1.2× 63 0.6× 69 0.9× 36 0.5× 60 0.9× 9 472
Yasuyuki Hitoshi Japan 10 267 1.1× 84 0.8× 55 0.7× 75 1.1× 32 0.5× 18 454
Sonja Mertsch Germany 18 299 1.2× 69 0.6× 97 1.3× 57 0.9× 29 0.4× 39 756
Tamara Vyshkina United States 13 321 1.3× 206 1.9× 105 1.4× 60 0.9× 175 2.7× 17 676
Ali Jalali United States 12 302 1.2× 102 0.9× 37 0.5× 117 1.8× 60 0.9× 40 602
Marisa Teigell France 10 178 0.7× 92 0.9× 60 0.8× 60 0.9× 52 0.8× 12 373
Dáša Doležalová Czechia 9 442 1.8× 53 0.5× 82 1.1× 116 1.8× 86 1.3× 10 573

Countries citing papers authored by Antje Arnold

Since Specialization
Citations

This map shows the geographic impact of Antje Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Arnold more than expected).

Fields of papers citing papers by Antje Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Arnold. The network helps show where Antje Arnold may publish in the future.

Co-authorship network of co-authors of Antje Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Arnold. A scholar is included among the top collaborators of Antje Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Arnold. Antje Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martin, Allison, Antje Arnold, Adrian Idrizi, et al.. (2024). DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically. Neuro-Oncology Advances. 6(1). vdae023–vdae023. 3 indexed citations
3.
4.
Maxwell, Micah J., Antje Arnold, Lijun Chen, et al.. (2021). Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma. Molecular & Cellular Proteomics. 20. 100123–100123. 5 indexed citations
5.
Arnold, Antje, et al.. (2021). EXTH-15. MULTI-FACETED INHIBITION OF TET PATHWAY WITH CELL-PERMEABLE 2HG AND BOBCAT 339 REDUCES PROLIFERATION AND INDUCES APOPTOSIS IN DIPG. Neuro-Oncology. 23(Supplement_6). vi166–vi166. 1 indexed citations
6.
Arnold, Antje, Eddie L. Imada, M. Lisa Zhang, et al.. (2020). Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma. Acta Neuropathologica Communications. 8(1). 62–62. 7 indexed citations
7.
Arnold, Antje, et al.. (2019). Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity. Neuro-Oncology. 22(4). 563–574. 24 indexed citations
8.
Martin, Allison, William R. Bell, Ming Yuan, et al.. (2019). PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status. Journal of Neuropathology & Experimental Neurology. 79(1). 74–85. 13 indexed citations
9.
Yuan, Ming, Antje Arnold, Heather M. Ames, et al.. (2018). MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Scientific Reports. 8(1). 12506–12506. 32 indexed citations
10.
Poore, Brad, Ming Yuan, Antje Arnold, et al.. (2018). Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin. Neuro-Oncology. 21(2). 252–263. 22 indexed citations
11.
Lyczek, Agatha, Antje Arnold, Jiangyang Zhang, et al.. (2017). Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin. Experimental Neurology. 291. 74–86. 35 indexed citations
12.
Poore, Brad & Antje Arnold. (2017). LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS. Neuro-Oncology. 19(suppl_4). iv36–iv36. 1 indexed citations
13.
Li, Shen, Ulf D. Kahlert, Eric H. Raabe, et al.. (2017). An immunocompetent mouse model of human glioblastoma. Oncotarget. 8(37). 61072–61082. 30 indexed citations
14.
Rohani, Leili, Heidrun Holland, Yahaira Naaldijk, et al.. (2016). Generation of human induced pluripotent stem cells using non-synthetic mRNA. Stem Cell Research. 16(3). 662–672. 30 indexed citations
15.
Rohani, Leili, Adiv A. Johnson, Antje Arnold, & Alexandra Stolzing. (2013). The aging signature: a hallmark of induced pluripotent stem cells?. Aging Cell. 13(1). 2–7. 68 indexed citations
16.
Arnold, Antje, Yahaira Naaldijk, Claire Fabian, et al.. (2011). Reprogramming of Human Huntington Fibroblasts Using mRNA. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 2012. 1–12. 13 indexed citations
17.
Visvanathan, Kala, Syed Z. Ali, A. Brewster, et al.. (2007). The Reliability of Nipple Aspirate and Ductal Lavage in Women at Increased Risk for Breast Cancer—a Potential Tool for Breast Cancer Risk Assessment and Biomarker Evaluation. Cancer Epidemiology Biomarkers & Prevention. 16(5). 950–955. 18 indexed citations
18.
Römpler, Holger, Hon‐Tsen Yu, Antje Arnold, Annie Orth, & Torsten Schöneberg. (2006). Functional consequences of naturally occurring DRY motif variants in the mammalian chemoattractant receptor GPR33. Genomics. 87(6). 724–732. 27 indexed citations
19.
Milošević, Javorina, Antje Arnold, Florian Wegner, et al.. (2006). Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling. Journal of Neurochemistry. 99(3). 913–923. 69 indexed citations
20.
Visvanathan, Kala, et al.. (2005). The reliability of ductal lavage in women at high risk for breast cancer. Journal of Clinical Oncology. 23(16_suppl). 1001–1001. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Pöschl Breakdown of academic impact, for papers by Anke Leinhaas Breakdown of academic impact, for papers by Dao Ly Breakdown of academic impact, for papers by Israel Ben‐Dor Breakdown of academic impact, for papers by Yasuyuki Hitoshi Breakdown of academic impact, for papers by Sonja Mertsch Breakdown of academic impact, for papers by Tamara Vyshkina Breakdown of academic impact, for papers by Ali Jalali Breakdown of academic impact, for papers by Marisa Teigell Breakdown of academic impact, for papers by Dáša Doležalová
Rankless by CCL
2026